NIH-funded research R01 grant

Understanding how children's immune systems respond to repeated malaria infections

Official title: Deciphering mechanisms of CD4+ T cell-dependent clinical immunity to repeated Plasmodium infections

Funded at Stanford University · NIH-11056878 · Data updated 2026-11-12

This study is looking at how kids' immune systems learn to fight off malaria infections without getting sick, by examining their blood to understand how certain immune cells work, which could lead to better ways to prevent and treat malaria in young children.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionStanford University
NIH-funded
Lab location1 site (Stanford, United States)
Project startMarch 15, 2024
Project endJanuary 31, 2029
Funding year2025
Award (this year)$643,506
NIH project number5R01AI177377-02
Project IDNIH-11056878 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are children aged 2 to 5 years who have experienced repeated malaria infections.

Less likely to help

Patients who have not had malaria infections or are older than 5 years may not benefit from this research.

What this research studies

This research investigates how children's immune systems, specifically CD4+ T cells, develop immunity to repeated malaria infections. It focuses on understanding the role of specialized immune cells that help children tolerate the malaria parasite without showing symptoms. By analyzing blood samples from children who have experienced multiple infections, the study aims to uncover the genetic and cellular mechanisms that contribute to this immunity. The findings could help improve malaria prevention strategies and treatment approaches for young children.

Why it matters

Potential benefit: If successful, this research could lead to better strategies for preventing severe malaria in children and enhancing their immune responses.

How similar studies have gone: Previous research has shown promising results in understanding immune responses to malaria, but this specific approach is novel and aims to fill existing knowledge gaps.

Where this research is happening

  • Stanford University
    Stanford, United States
    Active

Researchers

  • Principal investigator: Jagannathan, Prasanna — Stanford University
  • Study coordinator: Jagannathan, Prasanna

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.